Literature DB >> 7512789

Hypoplasia of the cerebellar vermis and corpus callosum in thrombocytopenia with absent radius syndrome on MRI studies.

M R MacDonald1, G B Schaefer, A H Olney, D F Patton.   

Abstract

Thrombocytopenia with absent radius (TAR) syndrome is infrequently (7%) associated with mental retardation. In those cases, the mental deficiency is presumed to be a consequence of intracranial hemorrhage due to the thrombocytopenia. We report on 2 infants with TAR syndrome. One had developmental delay with evidence of cerebral dysgenesis by magnetic resonance imaging (MRI). Such findings have not been noted in the literature, but may not have been investigated in most cases. The other infant with TAR syndrome, who has had normal psychomotor development, has a normal brain on MRI scan. Detailed neuroimaging studies, preferably MRI, should be considered in the evaluation of patients with TAR syndrome, especially when there are documented signs of developmental delay, with or without a history of intracranial hemorrhage.

Entities:  

Mesh:

Year:  1994        PMID: 7512789     DOI: 10.1002/ajmg.1320500111

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes.

Authors:  Jill A Rosenfeld; Ryan N Traylor; G Bradley Schaefer; Elizabeth W McPherson; Blake C Ballif; Eva Klopocki; Stefan Mundlos; Lisa G Shaffer; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

Review 2.  Nonsense-mediated mRNA decay: inter-individual variability and human disease.

Authors:  Lam Son Nguyen; Miles F Wilkinson; Jozef Gecz
Journal:  Neurosci Biobehav Rev       Date:  2013-11-14       Impact factor: 8.989

3.  Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system.

Authors:  Anna Ivanova; Jens Wuerfel; Juan Zhang; Olaf Hoffmann; Matthias Ballmaier; Christof Dame
Journal:  BMC Dev Biol       Date:  2010-07-28       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.